🔎 Trials Near Me

Home › Crohn's Disease › Georgia › Atlanta

Crohn's Disease clinical trials in Atlanta, GA

17 studies for Crohn's Disease are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RecruitingPhase 3
  • Morehouse School Of Medicine ( Site 5071), Atlanta
Ages 16 to 80 · All sexes · Updated Oct 2, 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RecruitingPhase 4
  • Digestive Healthcare of Georgia, Atlanta
  • AGA GA Research LLC, Atlanta
Ages 18 to 80 · All sexes · Updated Sep 30, 2026 · NCT06581328

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • Emory University, Atlanta
  • Children's Center for Digestive Health Care, Atlanta
Ages 2 to 17 · All sexes · Updated Sep 25, 2026 · NCT05923073

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • Morehouse School of Medicine, Atlanta
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 2/3
  • Emory University, Atlanta
  • Children's Center for Digestive Health Care, Atlanta
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07196722

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

RecruitingPhase 3
  • Emory University, Atlanta
  • Children's Center for Digestive Healthcare, Atlanta
Ages 3 and older · All sexes · Updated Sep 25, 2026 · NCT06663332

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 2
  • Emory University Hospital, The Emory Clinic, Atlanta
  • Atlanta Center For Gastroenterology, P.C., Decatur · 6 mi away
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06233461

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • Atlanta Gastroenterology Associates-Site Number: 8400109, Atlanta
Ages 16 to 80 · All sexes · Updated Sep 23, 2026 · NCT07184931

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

RecruitingPhase 2
  • Atlanta Gastroenterology Specialists, PC, Atlanta
  • Atlanta Gastroenterology Associates (Part of United Digestive), Atlanta
Ages 18 to 85 · All sexes · Updated Sep 22, 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

RecruitingPhase 2
  • Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

RecruitingPhase 3
  • Emory University School of Medicine, Atlanta
  • Children's Center for Digestive Health Care, LLC, Atlanta
Ages 2 to 19 · All sexes · Updated Sep 22, 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

RecruitingPhase 2
  • Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07483099

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

RecruitingPhase 3
  • Emory University, Atlanta
  • Children's Center for Digestive Health Care, LLC, Atlanta
Ages 2 to 17 · All sexes · Updated Aug 24, 2026 · NCT05509777

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

RecruitingPhase 4
  • Emory University, Atlanta
Ages 6 to 17 · All sexes · Updated May 27, 2026 · NCT05781152

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

RecruitingPhase 3
  • Childrens Center For Digestive Healthcare, Atlanta
Ages 2 and older · All sexes · Updated May 7, 2026 · NCT05442567

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

RecruitingPhase 3
  • Childrens Center For Digestive Healthcare, Atlanta
Ages 2 to 17 · All sexes · Updated May 5, 2026 · NCT04779320

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RecruitingPhase 2
  • Mirador Therapeutics Selected Site, Atlanta
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522

About Crohn's Disease

Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.

More about Crohn's Disease on MedlinePlus

Crohn's Disease trials in other cities

Other studies in Atlanta

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.